Alputon Inc. was founded at the Zhangjiang Hi-Tech Park, Shanghai, China, in April 2007 by a team of highly accomplished scientists and managers with over ten years work experiences in pharmaceutical and biotech industries in USA.

The company has adopted a service model to provide world class R&D services to global pharmaceutical and biotech industries with its initial focus in chemistry.

There are three key elements of the company, which distinguish Alputon Inc. from other service providers across the globe. First, a highly experienced scientific and managerial TEAM with proven track records in drug discovery is committed to directly managing your programs, to which the international standards of IP protection, work ethics, business conduct are applied. Secondly, the state of the art parallel synthesis and purification TECHNOLOGY PLATFORM ( eI2C ) acquired from ArQule Inc., coupled with highly competent traditional organic and medicinal chemistry skill sets, provides unique capabilities, capacity and speed in discovery chemistry for your programs. Thirdly, the customer-focused company CULTURE and western-type management style ensure that the success of our collaboration with you is our No. 1 priority and you can count on Alputon to deliver results.

The combination of those elements enables us to advance your programs such as hit generation, hit follow-up and expansion, and lead optimization as well as design and synthesis of templates and libraries, BETTER, FASTER AND CHEAPER.